Exponent, Inc. (EXPO)

NASDAQ:
EXPO
| Latest update: May 31, 2026, 6:19 PM

Stock events for Exponent, Inc. (EXPO)

In the past six months, Exponent reported strong first-quarter fiscal year 2026 results, exceeding estimates due to increased demand including AI-related work. Despite positive earnings, the stock price declined, hitting a 52-week low. Analysts adjusted price targets, but the consensus remains a "Moderate Buy" with an average target price of $85.00. A quarterly dividend of $0.31 per share was declared, and there were reports of insider selling.

Demand Seasonality affecting Exponent, Inc.’s stock price

Specific seasonality patterns are not publicly available, but demand is generally consistent due to critical reactive engagements. Recent reports indicate rising demand and AI-related demand as significant drivers for fiscal year 2026, suggesting growth influenced by technological advancements.

Overview of Exponent, Inc.’s business

Exponent, Inc. is a leading American science and engineering consulting firm providing multidisciplinary analysis and advisory services. It operates through two segments: Engineering and Other Scientific, and Environmental and Health. Services are categorized into Reactive (litigation support, investigations) and Proactive (product improvement, risk management). The company serves diverse sectors including chemicals, construction, and technology.

EXPO’s Geographic footprint

Exponent has a global presence with over 90 offices across North America, Europe, and Asia. In the United States, it has offices in Menlo Park, Phoenix, Natick, Massachusetts, and 21 other locations across 13 states and the District of Columbia. Internationally, Exponent has offices in China, Hong Kong, Singapore, Switzerland, and the United Kingdom.

EXPO Corporate Image Assessment

Exponent, Inc. maintains a strong brand reputation as a market leader in scientific and engineering consulting. The company is noted for its technical reputation and commitment to objectivity. No specific events negatively impacting Exponent's brand reputation in the past year were explicitly identified.

Ownership

Exponent, Inc. is predominantly owned by institutional shareholders, holding approximately 90.68% to 96.24% of the stock. Major institutional owners include BlackRock Inc., Vanguard Group Inc., Kayne Anderson Rudnick Investment Management LLC, Conestoga Capital Advisors, LLC, and State Street Corp. Insider ownership is relatively minor, ranging from 1.01% to 2.70%.

Expert AI

Show me the sentiment for Exponent, Inc.
What's the latest sentiment for Exponent, Inc.?

Price Chart

$58.32

0.17%
(1 month)

Top Shareholders

BlackRock, Inc.
12.36%
The Vanguard Group, Inc.
10.35%
Virtus Investment Partners, Inc.
8.30%
Conestoga Capital Advisors LLC
4.80%
State Street Corp.
3.72%
Geneva Capital Management LLC
3.46%
Geneva Management LLC
3.46%
Geode Holdings Trust
3.19%

Trade Ideas for EXPO

Today

Sentiment for EXPO

News
Social

Buzz Talk for EXPO

Today

Social Media

FAQ

What is the current stock price of Exponent, Inc.?

As of the latest update, Exponent, Inc.'s stock is trading at $58.32 per share.

What’s happening with Exponent, Inc. stock today?

Today, Exponent, Inc. stock is down by -0.17%, possibly due to news.

What is the market sentiment around Exponent, Inc. stock?

Current sentiment around Exponent, Inc. stock is positive, based on recent news, trading volume, and analyst opinions.

Is Exponent, Inc.'s stock price growing?

Over the past month, Exponent, Inc.'s stock price has decreased by -0.17%.

How can I buy Exponent, Inc. stock?

You can buy Exponent, Inc. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol EXPO

Who are the major shareholders of Exponent, Inc. stock?

Major shareholders of Exponent, Inc. include institutions such as BlackRock, Inc. (12.36%), The Vanguard Group, Inc. (10.35%), Virtus Investment Partners, Inc. (8.30%) ... , according to the latest filings.